China Medical & HealthCare Group Limited provided earnings guidance for the six months ended 30 November 2017. For the period, it is expected to record a loss attributable to shareholders of the Company for the six months ended 31 December 2017 as compared with a profit in 2016. The expected loss attributable to the shareholders of the Company was mainly due to (i) the reduction of gains in fair value change of investments held for trading and derivative financial instruments; (ii) the absence of reversal of impairment loss recognized on loan and interest receivables under the money lending business; (iii) reduction in sales of properties under the property development operations; and (iv) the reduction in the sales of independent living units (‘ILU’) under the Eldercare Division.